The Cerebellum as a Potential Treatment Site for PD Motor Symptoms
NCT ID: NCT02387346
Last Updated: 2015-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2015-04-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will each receive one session of stimulation in the ON state of medication. A pre-assessment will be performed before beginning the session and a post-assessment will be performed immediately following stimulation. There will be two groups, which will both undergo the exact same protocol, however one group will receive real stimulation, and one group will receive sham stimulation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease
NCT04238000
Repetitive Transcranial Magnetic Stimulation on Freezing of Gait in People With Parkinson's Disease
NCT04695496
Efficacy of Deep-coil Based Repetitive Transcranial Magnetic Stimulation in the Treatment of Parkinson's Disease With Freezing of Gait and Its Neural Regulation Mechanism Study of Resting-state Cerebral Blood Flow
NCT06888778
Transcranial Magnetic Stimulation in Parkinson's Disease
NCT00023062
The Role of Cerebellar Hyperactivity in Parkinson's Disease
NCT02349789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real Stimulation
Participants in this group will receive Repetitive Transcranial Magnetic Stimulation, characterized by 900 pulses at 1Hz over the medial cerebellum at 120% resting motor threshold of the right first dorsal interosseous.
Magstim Rapid 2 Repetitive Transcranial Magnetic Stimulation
Sham Stimulation
Participants will receive Sham Repetitive Transcranial Magnetic Stimulation by having the coil angled at 90 degrees to the scalp; this will allow adequate noise output from the stimulator in the absence on real magnetic stimulation.
Magstim Rapid 2 Sham Stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magstim Rapid 2 Repetitive Transcranial Magnetic Stimulation
Magstim Rapid 2 Sham Stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to walk 10 metres unassisted
* ability to stand for 5 minutes unassisted
* understand verbal instructions in English
Exclusion Criteria
* cochlear implants
* diagnosed with vascular Parkinson's disease
* history or increased risk of seizure
* severe dyskinesia of neck muscles
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Life Financial Movement Disorders Research and Rehabilitation Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Quincy J Almeida, PhD
Role: STUDY_DIRECTOR
SunLife Financial Movement Disorders Research & Rehabilitation Centre, Wilfrid Laurier University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun Life Financial Movement Disorders Research & Rehabilitation Centre
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4247
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.